跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TUSSIDEX FORTE LINCTUS 15 MG/5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
TUSSIDEX FORTE LINCTUS 15 MG/5 ML
Approved
THERAPEUTIC
TUSSIDEX FORTE LINCTUS 15 MG/5 ML
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
Jan 21, 1992
Approval ID
16b20e628c49fc17
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
16b20e628c49fc17
Drug Name
TUSSIDEX FORTE LINCTUS 15 MG/5 ML
Product Name
TUSSIDEX FORTE LINCTUS 15 MG/5 ML
Approval Number
SIN06770P
Approval Date
1992-01-21
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
ELIXIR
Route Of Administration
ORAL
Atc Code
R05DA09
Atc Item Name
dextromethorphan
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Company Detail Path
/organization/apex-pharma-marketing-pte-ltd
Active Ingredients
DEXTROMETHORPHAN HBr
15 mg/5 ml
DEXTROMETHORPHAN HBr
15 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 21, 1992
Approval ID
16b20e628c49fc17
Type
Therapeutic
Back to HSA Approvals